$1M+ Grant Award to Research ExerciseRx As Part of Cancer Care Through ‘The Get Moving’ Clinical Trial
The Bladder Cancer Advocacy Network (BCAN) awarded their first-ever Translational Clinical Trial Award (TCTA) to a collaborative effort between The Sports Institute at UW Medicine, UW Departments of Urology and Rehabilitation Medicine, and Fred Hutch Cancer Center. These funds will support anRCT evaluating a home-based (p)rehabilitation with ExerciseRx in patients with bladder cancer, aka “The Get Moving” Clinical Trial.
This research collaboration is led by Principal Investigators Dr. Sarah Psutka, Associate Professor of UW’s Urology in the Department of Urology and Fred Hutchinson Cancer Center and Dr. Cindy Lin, founder of ExerciseRx, Associate Director of Clinical Innovation at The Sports Institute, and Clinical Associate Professor in Sports and Spine Medicine in the Department of Rehabilitation Medicine. The goal of this research is to evaluate the ExerciseRx (p)rehabilitation intervention vs. standard care in patients undergoing treatment for bladder cancer with the goal of improving function and quality of life during cancer treatment.
If you would like to learn more about this research, please reach out to us via email.